Shortage of antimicrobial agents used in Tuberculosis (TB) treatment
The following antimicrobial medicines used to treat tuberculosis (TB) will be intermittently available until at least the end of 2025:
Rifampicin 150mg and 300mg capsules
Rifampicin 600mg IV solution for infusion
Rifampicin 100mg/5ml oral suspension
Rifinah® 300 tablets (rifampicin 300mg / isoniazid 150mg)
Rifater® tablets (rifampicin 120mg / isoniazid 50mg/ pyrazinamide 300mg)
Voractiv® tablets (rifampicin 150mg/ isoniazid 75mg / pyrazinamide 400mg / ethambutol 275mg)
Pyrazinamide 500mg tablets
Ethambutol tablets, Isoniazid tablets, and Rifinah® 150 tablets (rifampicin 150 mg / isoniazid 100 mg) and Mycobutin® (rifabutin) 150mg capsules remain available but cannot support a full increase in demand.
Source: Department of Health and Social Care